A
Andrea Lancia
Researcher at University of Pavia
Publications - 61
Citations - 1494
Andrea Lancia is an academic researcher from University of Pavia. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 12, co-authored 51 publications receiving 882 citations. Previous affiliations of Andrea Lancia include Geneva College & University of Paris-Sud.
Papers
More filters
Journal ArticleDOI
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun,Roger Sun,Elaine Johanna Limkin,Elaine Johanna Limkin,Maria Vakalopoulou,Maria Vakalopoulou,Laurent Dercle,Laurent Dercle,Stéphane Champiat,Shan Rong Han,Loic Verlingue,David Brandao,Andrea Lancia,Andrea Lancia,Andrea Lancia,Samy Ammari,Antoine Hollebecque,Jean-Yves Scoazec,Jean-Yves Scoazec,Aurélien Marabelle,Christophe Massard,Jean-Charles Soria,Jean-Charles Soria,Charlotte Robert,Nikos Paragios,Nikos Paragios,Eric Deutsch,Charles Ferté,Charles Ferté +28 more
TL;DR: A radiomic signature predictive of immunotherapy response by combining contrast-enhanced CT images and RNA-seq genomic data from tumour biopsies to assess CD8 cell tumour infiltration was developed and validated.
Journal ArticleDOI
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy.
Elise De Bleser,Barbara Alicja Jereczek-Fossa,Barbara Alicja Jereczek-Fossa,David Pasquier,Thomas Zilli,Nicholas van As,Nicholas van As,Shankar Siva,Andrei Fodor,Piet Dirix,Alfonso Gomez-Iturriaga,Fabio Trippa,Beatrice Detti,Gianluca Ingrosso,Luca Triggiani,Alessio Bruni,Filippo Alongi,Dries Reynders,Gert De Meerleer,Alessia Surgo,Kaoutar Loukili,Raymond Miralbell,Pedro Silva,Pedro Silva,Sarat Chander,Nadia Di Muzio,Ernesto Maranzano,Giulio Francolini,Andrea Lancia,Alison Tree,Alison Tree,Chiara Lucrezia Deantoni,Elisabetta Ponti,Giulia Marvaso,Els Goetghebeur,Piet Ost +35 more
TL;DR: It is hypothesized that ENRT should be preferred to SBRT in the treatment of nodal oligorecurrences, and this hypothesis needs to be evaluated in a randomized trial.
Journal ArticleDOI
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience.
Gianluca Ingrosso,Fabio Trippa,Ernesto Maranzano,Alessandra Carosi,Elisabetta Ponti,Fabio Arcidiacono,L. Draghini,Luana Di Murro,Andrea Lancia,Riccardo Santoni +9 more
TL;DR: This study demonstrates that SBRT is safe, effective, and minimally invasive in the eradication of limited nodal metastases, yielding an important delay in prescribing ADT.
Journal ArticleDOI
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani,Rosario Mazzola,Stefano Maria Magrini,Gianluca Ingrosso,Paolo Borghetti,Fabio Trippa,Andrea Lancia,Beatrice Detti,Giulio Francolini,Fabio Matrone,Roberto Bortolus,Giuseppe Fanetti,Ernesto Maranzano,Francesco Pasqualetti,Fabiola Paiar,Marco Lorenzo Bonù,Alessandro Magli,Alessio Bruni,Ercole Mazzeo,Ciro Franzese,Marta Scorsetti,Filippo Alongi,Barbara Alicja Jereczek-Fossa,Barbara Alicja Jereczek-Fossa,Piet Ost,Michela Buglione +25 more
TL;DR: SBRT appears to be a promising approach in oligoprogressive castration-resistant prostate cancer and further investigations are warranted.
Journal ArticleDOI
Current therapeutic options in metastatic castration-resistant prostate cancer
Gianluca Ingrosso,Beatrice Detti,Daniele Scartoni,Andrea Lancia,I. Giacomelli,M. Baki,G.A. Carta,Lorenzo Livi,Riccardo Santoni +8 more
TL;DR: All the approved pharmacologic treatment options for patients with mCRPC through 2018 are reviewed, analyzing the efficacy and possible side effects of each therapy to assist clinicians in reaching an appropriate treatment decision.